BioWorld MedTech

May 20, 2011

DES beauty contest pits device and patient criteria

PARIS – Participants can be quickly buried under an avalanche of new clinical trial results each year at EuroPCR, Europe's largest congress for interventional cardiologists. (Medical Device Daily) Read More

Is innovation going elsewhere? Well, yes, and here's why

Deals roundup: Thermo Fisher on the hunt to buy Phadia for $3.5 billion

Washington roundup: High court: FOIA docs not eligible for qui tam lawsuits

Report from Europe: Tryton gains CE mark for side branch stent

People in the News

MDD's food for med-tech thought

Agreements/contracts: Mitomics joins QDx to market QPredict

Clarification

Financings roundup: Metabolix commences public stock offering

Medtronic unveils data from CoreValve trials

Patents roundup: Zynx broadens scope of patent coverage in U.S.

HIT roundup: Texas hospital pioneers online effort to get patient feedback

Product Briefs

MDD's Diagnostic Extra

Today's news in brief

BioWorld

BioWorld briefs for Dec. 22, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 22, 2025.

Illustration of magnifying glass looking at cancer in the brain

Researchers discover how glioblastoma tumors dodge chemotherapy

BioWorld MedTech

Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...

Illustration of brain with electrical activity background

ABS-1230 controls seizures in KCNT1-driven severe epilepsy

BioWorld Science

Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...

Apollo’s APL-4098 shows potent antileukemic effects

BioWorld Science

Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.